Dendritic cells and macrophages are productively infected by poliovirus

Journal of Virology

Volumn 79, Issue 1, 2005, Pages 401-409

  Wahid, Rahnuma ^a   Cannon, Martin J ^a   Chow, Marie ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; ORAL POLIOMYELITIS VACCINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DEATH; CELL INTERACTION; CYTOLYSIS; DENDRITIC CELL; ENDOCYTOSIS; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; MACROPHAGE; MONOCYTE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS EXPRESSION; VIRUS STRAIN;

ANTIGEN PRESENTATION; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MACROPHAGES; MONOCYTES; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; PROTEINS;

EID: 10644270663     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.1.401-409.2005     Document Type: Article

References (52)

1. Agol, V. I., G. A. Belov, K. Bienz, D. Egger, M. S. Kolesnikova, L. I. Romanova, L. V. Sladkova, and E. A. Tolskaya. 2000. Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle. J. Virol. 74:5534-5541.
2. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89.
3. Ammendolia, M. G., A. Tinari, A. Calcabrini, and F. Superti. 1999. Poliovirus infection induces apoptosis in CaCo-2 cells. J. Med. Virol. 59:122-129.
4. + cytotoxic T lymphocytes. Eur. J. Immunol. 26:2595-2600.
5. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
6. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
7. Bouchard, M. J., and V. R. Racaniello. 1997. CD44 is not required for poliovirus replication. J. Virol. 71:2793-2798.
8. Boussadia, O., M. Niepmann, L. Creancier, A. C. Prats, F. Dautry, and H. Jacquemin-Sablon. 2003. Unr is required in vivo for efficient initiation of translation from the internal ribosome entry sites of both rhinovirus and poliovirus. J. Virol. 77:3353-3359.
9. Brossart, P., and M. J. Bevan. 1997. Presentation of exogenous protein antigens on major histocompatability complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90:1594-1599.
10. Chapuis, F., M. Rosenzwajg, M. Yagello, M. Ekman, P. Biberfeld, and J. C. Gluckman. 1997. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 27:431-441.
11. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1:510-514.
12. Chomarat, P., C. Dantin, L. Bennett, J. Banchereau, and A. K. Palucka. 2003. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 171:2262-2269.
13. high murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165:49-58.
14. Deitz, S. B., D. A. Dodd, S. Cooper, P. Parham, and K. Kirkegaard. 2000. MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc. Natl. Acad. Sci. USA 97:13790-13795.
15. DeTulleo, L., and T. Kirchhausen. 1998. The clathrin endocytic pathway in viral infection. EMBO J. 17:4585-4593.
16. Dodd, D. A., T. H. Giddings, Jr., and K. Kirkegaard. 2001. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon) secretion during viral infection. J. Virol. 75:8158-8165.
17. Doedens, J. R., and K. Kirkegaard. 1995. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14:894-907.
18. Eberle, K. E., V. T. Nguyen, and M. S. Freistadt. 1995. Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes. Arch. Virol. 140:2135-2150.
19. Fonteneau, J. F., M. Larsson, and N. Bhardwaj. 2002. Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses. Curr. Opin. Immunol. 14:471-477.
20. Fonteneau, J. F., D. G. Kavanagh, M. Lirvall, C. Sanders, T. L. Cover, N. Bhardwaj, and M. Larsson. 2003. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102:4448-4455.
21. Freistadt, M. S., and K. E. Eberle. 1996. Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J. Virol. 70:6486-6492.
22. Freistadt, M. S., H. B. Fleit, and E. Wimmer. 1993. Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication. Virology 195:798-803.
23. Gamarnik, A. V., and R. Andino. 1996. Replication of poliovirus in Xenopus oocytes requires two human factors. EMBO J. 15:5988-5998.
24. Graham, S., E. C. Wang, O. Jenkins, and L. K. Borysiewicz. 1993. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J. Virol. 67:1627-1637.
25. Gromeier, M., B. Bessert, M. Arita, A. Nomoto, and E. Wimmer. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 73:958-964.
26. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-667.
27. Gutierrez, A. L., M. Denova-Ocampo, V. R. Racaniello, and R. M. del Angel. 1997. Attenuating mutations in the poliovirus 5′ untranslated region alter its interaction with polypyrimidine tract-binding protein. J. Virol. 71:3826-3833.
28. Haller, A. A., S. R. Stewart, and B. L. Semler. 1996. Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J. Virol. 70:1467-1474.
29. Hogg, K., G. Hogg, R. Lester, and E. Uren. 2002. Immunity to poliomyelitis in Victorians. Aust. N. Z. J. Public Health 26:432-436.
30. Holland, J. J., and B. H. Hoyer. 1962. Early stages of enterovirus infection. Cold Spring Harbor Symp. Quant. Biol. 27:101-112.
31. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. R. Sousa, R. N. Germain, I. Mellman, and R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927-936.
32. Kaariainen, L., and M. Ranki. 1984. Inhibition of cell functions by RNA-virus infections. Annu. Rev. Microbiol. 38:91-109.
33. Kabir, J., M. Lobo, and I. Zachary. 2002. Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis. Biochem. J. 367:145-155.
34. La Monica, N., and V. R. Racaniello. 1989. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63:2357-2360.
35. Lange, R., X. Peng, E. Wimmer, M. Lipp, and G. Bernhardt. 2001. The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 285:218-227.
36. + splenic dendritic cells. Blood 103:2668-2676.
37. Lopez-Guerrero, J. A., M. Alonso, F. Martin-Belmonte, and L. Carrasco. 2000. Poliovirus induces apoptosis in the human U937 promonocytic cell line. Virology 272:250-256.
38. Lopez-Guerrero, J. A., C. Cabanas, C. Bernabeu, M. Fresno, and M. A. Alonso. 1991. Effects of poliovirus replication on undifferentiated and differentiated monocytic U937 cells: comparative studies with human macrophages. Intervirology 32:137-148.
39. Lopez-Guerrero, J. A., L. Carrasco, F. Martinez-Abarca, M. Fresno, and M. A. Alonso. 1989. Restriction of poliovirus RNA translation in a human monocytic cell line. Eur. J. Biochem. 186:577-582.
40. Mendelsohn, C., B. Johnson, K. A. Lionetti, P. Nobis, E. Wimmer, and V. R. Racaniello. 1986. Transformation of a human poliovirus receptor gene into mouse cells. Proc. Natl. Acad. Sci. USA 83:7845-7849.
41. Okada, Y., G. Toda, H. Oka, A. Nomoto, and H. Yoshikura. 1987. Poliovirus infection of established human blood cell lines: relationship between the differentiation stage and susceptibility of cell killing. Virology 156:238-245.
42. Polyak, S., H. Chen, D. Hirsch, I. George, R. Hershberg, and K. Sperber. 1997. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection. J. Immunol. 159:2177-2188.
43. Rodriguez, A., A. Regnault, M. Kleijmeer, P. Ricciardi-Castagnoli, and S. Amigorena. 1999. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1:362-368.
44. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
45. Santambrogio, L., A. K. Sato, G. J. Carven, S. L. Belyanskaya, J. L. Strominger, and L. J. Stern. 1999. Extracellular antigen processing and presentation by immature dendritic cells. Proc. Natl. Acad. Sci. USA 96: 15056-15061.
46. Santin, A. D., P. L. Hermonat, A. Ravaggi, M. Chiriva-Internati, M. J. Cannon, J. C. Hiserodt, S. Pecorelli, and G. P. Parham. 1999. Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro. Immunobiology 200:187-204.
47. Sarnow, P. 1989. Role of 3′-end sequences in infectivity of poliovirus transcripts made in vitro. J. Virol. 63:467-470.
48. Schaefer, A., R. Zibirre, P. Kabus, J. Kuhne, and G. Koch. 1982. Alterations in plasma-membrane functions after poliovirus infection. Biosci. Rep. 2:613-615.
49. Simons, J., M. Kutubuddin, and M. Chow. 1993. Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J. Virol. 67:1262-1268.
50. Taffs, R. E., Y. V. Chernokhvostova, E. M. Dragunsky, T. Nomura, K. Hioki, E. C. Beuvery, E. A. Fitzgerald, I. S. Levenbook, and D. M. Asher. 1997. Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge. J. Infect. Dis. 175:441-444.
51. Toyoda, H., N. Koide, M. Kamiyama, K. Tobita, K. Mizumoto, and N. Imura. 1994. Host factors required for internal initiation of translation on poliovirus RNA. Arch. Virol. 138:1-15.
52. Winter, P. A., J. D. Krynauw, and G. A. Marais. 1981. Artificial herd immunity to poliomyelitis in a semirural community in South Africa. S. Afr. Med. J. 60:889-890.